SAN CARLOS, Calif., Dec. 4, 2019 /PRNewswire/ -- RubrYc Therapeutics, Inc., a pre-clinical company developing therapeutic antibodies for the treatment of cancer and autoimmune diseases, today announced the creation of its Scientific Advisory Board (SAB) to support RubrYc's management...
from PR Newswire: https://ift.tt/2rUcKA0
No comments:
Post a Comment